Document is current
Any future updates will be listed below
-
Authors
Newson, Rachel S.
Spaepen, Erik
Liao, Birong
Bower, Julie
Bhattacharya, Indranil
Artime, Esther
Polonsky, William
- License Information
-
More Information
Article History
Received: 13 July 2023
Accepted: 15 April 2024
First Online: 22 April 2024
Declarations
:
: Ethical approval was provided by the Ethical & Independent Review Service (eandireview.com, E&I Study Number 21052–01, approved on 16-Nov-2021). Informed consent was obtained as part of the survey administration. This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Pharmacoepidemiology Practices and applicable laws and regulations of the country or countries where the study was conducted, as appropriate.
: Not applicable.
: RSN, BL, JB, IB, and EA are employees and shareholders of Eli Lilly and Company; ES is a contractor funded by Eli Lilly and Company; WP has served as a consultant for Eli Lilly, Sanofi, Novo Nordisk and Mannkind outside the submitted work.
